Report Code : CVMI2603252601429 | Published Date : March 30, 2025

1 | Market Overview
The global chlamydia infection diagnostics market is expanding rapidly due to increasing awareness of sexually transmitted infections (STIs), expanding government screening programs, and growing adoption of point-of-care (POC) diagnostic solutions. Chlamydia trachomatis is the most frequently reported bacterial STI worldwide, often asymptomatic but capable of causing severe complications like infertility and pelvic inflammatory disease if left untreated.

Growth is driven by advancements in molecular diagnostics, nucleic acid amplification tests (NAATs), rapid antigen tests, and home-based self-testing kits. Improved public health efforts and the need for early, accurate, and accessible diagnosis are propelling this market forward.

 

2 | Market Size and Forecast

Year

Market Value (USD Billion)

Notes

2019

1.82

Historical benchmark

2024

3.09

Five-year CAGR 10.6%

2031

7.14

Seven-year CAGR 12.3%

The market is expected to more than double by 2031, driven by technological innovations and expanded STI screening initiatives.

 

3 | Key Market Drivers

  • Rising Global Incidence of Chlamydia Infections.
  • Expansion of Public Health Screening Programs.
  • Adoption of Rapid and Point-of-Care (POC) Diagnostics.
  • Growth in Home-Based Self-Testing Solutions.
  • Technological Advancements in NAAT and PCR Platforms.

 

4 | Market Challenges

  • Social Stigma Limiting Testing Uptake in Some Regions.
  • High Cost of Advanced Molecular Diagnostics.
  • Limited Access in Low-Income Countries.
  • False Negatives in Some Rapid Antigen Tests.

 

5 | Competitive Landscape
The chlamydia diagnostics market is moderately consolidated, with leading players offering molecular, immunoassay, and POC diagnostic kits.

Market Share Estimates (2024):

Company

Estimated Market Share

Key Products

Abbott Laboratories

22%

Alinity m STI Assay, ID NOW™ POC tests

Hologic, Inc.

19%

Aptima® Combo 2 NAAT

Danaher Corporation (Cepheid)

17%

GeneXpert® CT/NG test

F. Hoffmann-La Roche Ltd

14%

cobas® CT/NG assay

Others (BD, Bio-Rad, Quidel, regional OEMs)

28%

Rapid POC kits and molecular diagnostics

 

6 | Market Segmentation
By Test Type:

  • Nucleic Acid Amplification Tests (NAATs)
  • Direct Fluorescent Antibody (DFA) Tests
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Rapid Antigen Detection Tests
  • Others (Culture Tests)

 

By End User:

  • Hospitals
  • Diagnostic Laboratories
  • Clinics & Sexual Health Centers
  • Home Care (Self-Testing Kits)
  • Research Institutes

 

By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

 

7 | Strategic Outlook
The future of the chlamydia diagnostics market will be shaped by AI-driven diagnostic platforms, smartphone-enabled home testing kits, and expanded telehealth integration. Market growth will also be supported by global STI awareness campaigns and governmental funding for widespread screening.





Reasons To Buy

Image



Scope

Image

Key Players

  • Abbott
  • Roche
  • BioMérieux
  • Thermo Fisher Scientific
  • BD (Becton Dickinson)
  • Siemens Healthineers
  • Danaher

Global Chlamydia Infection Diagnostics Market Report


  1. 1. Global Chlamydia Infection Diagnostics Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Global Chlamydia Infection Diagnostics Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
  2. 2. Global Chlamydia Infection Diagnostics Market Research Report - Preface
    1. 2.1 Global Chlamydia Infection Diagnostics Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Test Type
      2. 2.1.2 By End User
      3. 2.1.3 By Region
  3. 3. Global Chlamydia Infection Diagnostics Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Test Type, By End User, By Country
    3. 3.3. Opportunities – By Test Type, By End User, By Country
    4. 3.4. Trends – By Test Type, By End User, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Global Chlamydia Infection Diagnostics Market Research Report – DROTs Impact Analysis
    1. 4. Global Chlamydia Infection Diagnostics Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    2. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    4. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    5. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 5. Global Chlamydia Infection Diagnostics Market, By Test Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Nucleic Acid Amplification Tests (NAATs)
    2. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 5.2 Direct Fluorescent Antibody (DFA) Tests
    7. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 5.3 Enzyme-Linked Immunosorbent Assay (ELISA)
    12. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    16. 5.4 Rapid Antigen Detection Tests
    17. 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    18. 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    19. 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    20. 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    21. 5.5 Others (Culture Tests)
    22. 5.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    23. 5.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    24. 5.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    25. 5.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Global Chlamydia Infection Diagnostics Market, By End User, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Hospitals
    2. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 6.2 Diagnostic Laboratories
    7. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 6.3 Clinics & Sexual
    12. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    16. 6.4 Health Centers Home Care (Self-Testing Kits)
    17. 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    18. 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    19. 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    20. 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    21. 6.5 Research Institutes
    22. 6.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    23. 6.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    24. 6.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    25. 6.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 7. Global Chlamydia Infection Diagnostics Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 North America
      1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      7.2 Europe
      1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      7.3 Asia-Pacific
      1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      7.4 Latin America
      1. 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      7.5 Middle East and Africa
      1. 7.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      7.6 Global Chlamydia Infection Diagnostics Market - Opportunity Analysis Index, By Test Type, By End User, and Region, 2024 - 2031
  1. 8. North America Global Chlamydia Infection Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 By Test Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.1.1 Nucleic Acid Amplification Tests (NAATs)
      2. 8.1.2 Direct Fluorescent Antibody (DFA) Tests
      3. 8.1.3 Enzyme-Linked Immunosorbent Assay (ELISA)
      4. 8.1.4 Rapid Antigen Detection Tests
      5. 8.1.5 Others (Culture Tests)
      8.2 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.2.1 Hospitals
      2. 8.2.2 Diagnostic Laboratories
      3. 8.2.3 Clinics & Sexual
      4. 8.2.4 Health Centers Home Care (Self-Testing Kits)
      5. 8.2.5 Research Institutes
      8.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.3.1 United States
      2. 8.3.2 Canada
    2. 8.4 North America Global Chlamydia Infection Diagnostics Market – Opportunity Analysis Index, By Test Type, By End User, and Country, 2024 - 2031
    3. 8.5 Regional Trends Analysis
    4. 8.6 North America Global Chlamydia Infection Diagnostics Market Research Report - Company Profiles
      1. 8.6.1 Company 1 (United States)
      2. 8.6.2 Company 2 (Canada)
      3. 8.6.3 Company 3 (Canada)
    9. Europe Global Chlamydia Infection Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 By Test Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.1.1 Nucleic Acid Amplification Tests (NAATs)
      2. 9.1.2 Direct Fluorescent Antibody (DFA) Tests
      3. 9.1.3 Enzyme-Linked Immunosorbent Assay (ELISA)
      4. 9.1.4 Rapid Antigen Detection Tests
      5. 9.1.5 Others (Culture Tests)
      9.2 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.2.1 Hospitals
      2. 9.2.2 Diagnostic Laboratories
      3. 9.2.3 Clinics & Sexual
      4. 9.2.4 Health Centers Home Care (Self-Testing Kits)
      5. 9.2.5 Research Institutes
      9.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.3.1 Germany
      2. 9.3.2 United Kingdom
      3. 9.3.3 France
      4. 9.3.4 Spain
      5. 9.3.5 Italy
      6. 9.3.6 Russia
      7. 9.3.7 Netherlands and Rest of Europe
    2. 9.4 Europe Global Chlamydia Infection Diagnostics Market – Opportunity Analysis Index, By Test Type, By End User, and Country, 2024 - 2031
    3. 9.5 Regional Trends Analysis
    4. 9.6 Europe Global Chlamydia Infection Diagnostics Market Research Report - Company Profiles
      1. 9.6.1 Company 1 (Germany)
      2. 9.6.2 Company 2 (United Kingdom)
      3. 9.6.3 Company 3 (United Kingdom)
    10. Asia-Pacific Global Chlamydia Infection Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 10.1 By Test Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.1.1 Nucleic Acid Amplification Tests (NAATs)
      2. 10.1.2 Direct Fluorescent Antibody (DFA) Tests
      3. 10.1.3 Enzyme-Linked Immunosorbent Assay (ELISA)
      4. 10.1.4 Rapid Antigen Detection Tests
      5. 10.1.5 Others (Culture Tests)
      10.2 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.2.1 Hospitals
      2. 10.2.2 Diagnostic Laboratories
      3. 10.2.3 Clinics & Sexual
      4. 10.2.4 Health Centers Home Care (Self-Testing Kits)
      5. 10.2.5 Research Institutes
      10.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.3.1 China
      2. 10.3.2 Japan
      3. 10.3.3 India
      4. 10.3.4 South Korea
      5. 10.3.5 Australia & New Zealand
      6. 10.3.6 ASEAN
      7. 10.3.7 Rest of Asia-Pacific
    2. 10.4 Asia-Pacific Global Chlamydia Infection Diagnostics Market – Opportunity Analysis Index, By Test Type, By End User, and Country, 2024 - 2031
    3. 10.5 Regional Trends Analysis
    4. 10.6 Asia-Pacific Global Chlamydia Infection Diagnostics Market Research Report - Company Profiles
      1. 10.6.1 Company 1 (China)
      2. 10.6.2 Company 2 (Japan)
      3. 10.6.3 Company 3 (Japan)
    11. Latin America Global Chlamydia Infection Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 11.1 By Test Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 Nucleic Acid Amplification Tests (NAATs)
      2. 11.1.2 Direct Fluorescent Antibody (DFA) Tests
      3. 11.1.3 Enzyme-Linked Immunosorbent Assay (ELISA)
      4. 11.1.4 Rapid Antigen Detection Tests
      5. 11.1.5 Others (Culture Tests)
      11.2 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 Hospitals
      2. 11.2.2 Diagnostic Laboratories
      3. 11.2.3 Clinics & Sexual
      4. 11.2.4 Health Centers Home Care (Self-Testing Kits)
      5. 11.2.5 Research Institutes
      11.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 Brazil
      2. 11.3.2 Mexico
      3. 11.3.3 Argentina
      4. 11.3.4 Peru
      5. 11.3.5 Colombia
      6. 11.3.6 Rest of Latin America
    2. 11.4 Latin America Global Chlamydia Infection Diagnostics Market – Opportunity Analysis Index, By Test Type, By End User, and Country, 2024 - 2031
    3. 11.5 Regional Trends Analysis
    4. 11.6 Latin America Global Chlamydia Infection Diagnostics Market Research Report - Company Profiles
      1. 11.6.1 Company 1 (Brazil)
      2. 11.6.2 Company 2 (Mexico)
      3. 11.6.3 Company 3 (Mexico)
    12. Middle East and Africa Global Chlamydia Infection Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 12.1 By Test Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 Nucleic Acid Amplification Tests (NAATs)
      2. 12.1.2 Direct Fluorescent Antibody (DFA) Tests
      3. 12.1.3 Enzyme-Linked Immunosorbent Assay (ELISA)
      4. 12.1.4 Rapid Antigen Detection Tests
      5. 12.1.5 Others (Culture Tests)
      12.2 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 Hospitals
      2. 12.2.2 Diagnostic Laboratories
      3. 12.2.3 Clinics & Sexual
      4. 12.2.4 Health Centers Home Care (Self-Testing Kits)
      5. 12.2.5 Research Institutes
      12.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 Saudi Arabia
      2. 12.3.2 UAE
      3. 12.3.3 Qatar
      4. 12.3.4 Egypt
      5. 12.3.5 Israel
      6. 12.3.6 Rest of Middle East and Africa
    2. 12.4 Middle East and Africa Global Chlamydia Infection Diagnostics Market – Opportunity Analysis Index, By Test Type, By End User, and Country, 2024 - 2031
    3. 12.5 Regional Trends Analysis
    4. 12.6 Middle East and Africa Global Chlamydia Infection Diagnostics Market Research Report - Company Profiles
      1. 12.6.1 Company 1 (Saudi Arabia)
      2. 12.6.2 Company 2 (UAE)
      3. 12.6.3 Company 3 (UAE)
    13. Competition Landscape
    1. 13.1 Strategic Dashboard of Top Market Players
    2. 13.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 13.2.1 Abbott
      2. 13.2.2 Roche
      3. 13.2.3 BioMérieux
      4. 13.2.4 Thermo Fisher Scientific
      5. 13.2.5 BD (Becton Dickinson)
      6. 13.2.6 Siemens Healthineers
      7. 13.2.7 Danaher
  1. 14. Data Collection Method and Research Approach
  2. 15. Principal Presumptions and Acronyms